NASDAQ : MBOT
Microbot Medical Inc. — Financial statements
Healthcare · Medical Instruments & Supplies · United States
Last price 1.12 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 75.22M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 12.27M | 8.73M | 5.22M | 4.34M | 5.77M | 5.41M |
| Research & Development | 5.60M | 6.01M | 6.41M | 5.51M | 7.51M | 5.95M |
| Operating Expenses | 17.87M | 14.74M | 11.62M | 9.86M | 13.28M | 11.36M |
| Operating Income | -18.51M | -14.74M | -11.62M | -9.86M | -13.28M | -11.36M |
| Interest & Investment Income | 2.17M | 1.28M | 182.00K | 228.00K | 118.00K | 44.00K |
| Other Non Operating Income (Expenses) | 316.00K | 316.00K | ||||
| EBT Excluding Unusual Items | -16.02M | -13.14M | -11.44M | -9.63M | -13.16M | -11.31M |
| Gain (Loss) on Sale of Assets | -2.00K | -5.00K | ||||
| Legal Settlements | -316.00K | -1.11M | ||||
| Pretax Income | -16.34M | -13.14M | -11.44M | -10.74M | -13.17M | -11.31M |
| Net Income | -16.34M | -13.14M | -11.44M | -10.74M | -13.17M | -11.31M |
| Net Income to Common | -16.34M | -13.14M | -11.44M | -10.74M | -13.17M | -11.31M |
| Shares Outstanding (Basic) | 62.47M | 45.79M | 15.64M | 10.20M | 7.26M | 7.11M |
| Shares Outstanding (Diluted) | 62.47M | 45.79M | 15.64M | 10.20M | 7.26M | 7.11M |
| EPS (Basic) | -0.26 | -0.29 | -0.73 | -1.05 | -1.81 | -1.59 |
| EPS (Diluted) | -0.26 | -0.29 | -0.73 | -1.05 | -1.81 | -1.59 |
| Free Cash Flow | -17.93M | -13.11M | -8.85M | -8.57M | -11.63M | -9.42M |
| Free Cash Flow Per Share | -0.29 | -0.29 | -0.57 | -0.84 | -1.60 | -1.33 |
| EBITDA | -18.46M | -14.70M | -11.53M | -9.75M | -13.18M | -11.28M |
| D&A For EBITDA | 47.00K | 47.00K | 91.00K | 106.00K | 102.00K | 76.00K |
| EBIT | -18.51M | -14.74M | -11.62M | -9.86M | -13.28M | -11.36M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.15M | 3.91M | 3.11M | 2.47M | 2.44M | 13.49M |
| Short-Term Investments | 64.22M | 74.68M | 2.36M | 3.92M | 5.76M | 2.00M |
| Cash & Short-Term Investments | 67.37M | 78.59M | 5.47M | 6.38M | 8.21M | 15.49M |
| Other Receivables | 241.00K | 89.00K | 1.40M | 103.00K | 174.00K | |
| Receivables | 176.00K | 241.00K | 89.00K | 1.40M | 103.00K | 174.00K |
| Inventory | 2.91M | 584.00K | ||||
| Prepaid Expenses | 709.00K | 403.00K | 211.00K | 91.00K | 429.00K | 126.00K |
| Restricted Cash | 200.00K | 2.00K | 49.00K | 49.00K | 77.00K | 87.00K |
| Other Current Assets | 814.00K | |||||
| Total Current Assets | 72.17M | 79.82M | 5.82M | 7.92M | 8.81M | 15.88M |
| Property, Plant & Equipment | 1.12M | 926.00K | 212.00K | 406.00K | 723.00K | 888.00K |
| Other Long-Term Assets | 76.00K | 796.00K | ||||
| Total Assets | 73.36M | 81.54M | 6.03M | 8.33M | 9.54M | 16.77M |
| Accounts Payable | 871.00K | 511.00K | 165.00K | 357.00K | 116.00K | 279.00K |
| Accrued Expenses | 2.69M | 2.52M | 2.22M | 1.03M | 1.67M | 1.43M |
| Current Portion of Leases | 326.00K | 296.00K | 70.00K | 191.00K | 283.00K | 278.00K |
| Current Unearned Revenue | 93.00K | |||||
| Other Current Liabilities | 5.00K | 5.00K | 2.21M | |||
| Total Current Liabilities | 3.89M | 3.42M | 2.46M | 3.79M | 2.07M | 1.98M |
| Long-Term Leases | 550.00K | 569.00K | 41.00K | 40.00K | 179.00K | 402.00K |
| Total Liabilities | 4.44M | 3.99M | 2.50M | 3.83M | 2.25M | 2.39M |
| Common Stock | 672.00K | 672.00K | 195.00K | 118.00K | 80.00K | 72.00K |
| Additional Paid-In Capital | 181.64M | 180.97M | 94.28M | 83.88M | 75.97M | 69.90M |
| Retained Earnings | -113.38M | -104.09M | -90.94M | -79.50M | -68.76M | -55.59M |
| Shareholders' Equity | 68.93M | 77.55M | 3.53M | 4.50M | 7.29M | 14.38M |
| Total Liabilities & Equity | 73.36M | 81.54M | 6.03M | 8.33M | 9.54M | 16.77M |
| Total Debt | 876.00K | 865.00K | 111.00K | 231.00K | 462.00K | 680.00K |
| Net Cash (Debt) | 66.49M | 77.73M | 5.36M | 6.15M | 7.74M | 14.81M |
| Net Cash Per Share | 1.06 | 1.70 | 0.34 | 0.60 | 1.07 | 2.08 |
| Filing Date Shares Outstanding | 67.16M | 67.16M | 34.74M | 14.40M | 8.13M | 7.11M |
| Total Common Shares Outstanding | 67.16M | 67.16M | 19.40M | 11.71M | 7.89M | 7.11M |
| Working Capital | 68.28M | 76.40M | 3.36M | 4.13M | 6.75M | 13.89M |
| Book Value Per Share | 1.03 | 1.15 | 0.18 | 0.38 | 0.92 | 2.02 |
| Tangible Book Value | 68.93M | 77.55M | 3.53M | 4.50M | 7.29M | 14.38M |
| Tangible Book Value Per Share | 1.03 | 1.15 | 0.18 | 0.38 | 0.92 | 2.02 |
| Machinery | 495.00K | 435.00K | 410.00K | 379.00K | 304.00K | |
| Leasehold Improvements | 229.00K | 229.00K | 229.00K | 229.00K | 229.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -16.34M | -13.14M | -11.44M | -10.74M | -13.17M | -11.31M |
| Depreciation & Amortization | 47.00K | 47.00K | 91.00K | 106.00K | 102.00K | 76.00K |
| Loss (Gain) From Sale of Assets | 2.00K | 5.00K | ||||
| Stock-Based Compensation | 1.22M | 1.06M | 1.35M | 1.39M | 1.75M | 1.39M |
| Other Operating Activities | -96.00K | -1.00K | 2.05M | -12.00K | ||
| Change in Accounts Receivable | -176.00K | |||||
| Change in Inventory | -2.91M | -584.00K | ||||
| Change in Accounts Payable | 1.62M | 495.00K | 873.00K | -683.00K | -241.00K | 320.00K |
| Change in Other Net Operating Assets | -1.01M | -919.00K | 304.00K | -663.00K | 13.00K | 177.00K |
| Operating Cash Flow | -17.64M | -13.05M | -8.83M | -8.53M | -11.55M | -9.35M |
| Capital Expenditures | -288.00K | -60.00K | -25.00K | -33.00K | -84.00K | -69.00K |
| Investment in Securities | -35.53M | -72.32M | 1.56M | 2.01M | -3.75M | 3.27M |
| Investing Cash Flow | -36.78M | -72.38M | 1.54M | 1.97M | -3.84M | 3.20M |
| Issuance of Common Stock | 53.70M | 86.24M | 7.94M | 6.56M | 4.32M | |
| Financing Cash Flow | 53.70M | 86.24M | 7.94M | 6.56M | 4.32M | |
| Net Cash Flow | -720.00K | 810.00K | 646.00K | -2.00K | -11.06M | -6.15M |
| Free Cash Flow | -17.93M | -13.11M | -8.85M | -8.57M | -11.63M | -9.42M |
| Free Cash Flow Per Share | -0.29 | -0.29 | -0.57 | -0.84 | -1.60 | -1.33 |
| Levered Free Cash Flow | -14.24M | -8.32M | -5.87M | -3.81M | -6.67M | -4.94M |
| Unlevered Free Cash Flow | -14.24M | -8.32M | -5.87M | -3.81M | -6.67M | -4.94M |
| Change in Working Capital | -2.47M | -1.01M | 1.18M | -1.35M | -228.00K | 497.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 75.61M | 134.32M | 18.96M | 19.20M | 23.75M | 53.31M |
| Enterprise Value | 9.12M | 55.06M | 14.72M | 11.29M | 17.92M | 35.59M |
| Last Close Price | 1.09 | 2.00 | 1.12 | 1.64 | 3.01 | 7.50 |
| PB Ratio | 1.06 | 1.73 | 5.37 | 4.27 | 3.26 | 3.71 |
| P/TBV Ratio | 1.06 | 1.73 | 5.37 | 4.27 | 3.26 | 3.71 |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.03 | 0.05 | 0.06 | 0.05 |
| Net Debt / Equity Ratio | -0.96 | -1.00 | -1.52 | -1.37 | -1.06 | -1.03 |
| Net Debt / EBITDA Ratio | 3.60 | 5.29 | 0.47 | 0.63 | 0.59 | 1.31 |
| Net Debt / FCF Ratio | 3.71 | 5.93 | 0.60 | 0.72 | 0.67 | 1.57 |
| Quick Ratio | 17.37 | 23.04 | 2.26 | 2.06 | 4.01 | 7.90 |
| Current Ratio | 18.56 | 23.33 | 2.37 | 2.09 | 4.26 | 8.00 |
| Return on Equity (ROE) | -32.91% | -32.42% | -284.97% | -182.19% | -121.53% | -58.48% |
| Return on Assets (ROA) | -21.72% | -21.04% | -101.21% | -68.96% | -63.11% | -32.98% |
| Return on Capital Employed (ROCE) | -26.60% | -18.90% | -325.50% | -217.00% | -177.80% | -76.80% |
| Earnings Yield | -23.23% | -9.78% | -60.34% | -55.94% | -55.44% | -21.22% |
| FCF Yield | -24.49% | -9.76% | -46.68% | -44.62% | -48.98% | -17.68% |
| Buyback Yield / Dilution | -146.72% | -192.69% | -53.38% | -40.49% | -2.14% | 0.14% |